Skip to main content

Arazlo FDA Approval History

Last updated by Judith Stewart, BPharm on Jan 15, 2020.

FDA Approved: Yes (First approved December 18, 2019)
Brand name: Arazlo
Generic name: tazarotene
Dosage form: Lotion
Company: Bausch Health Companies Inc.
Treatment for: Acne

Arazlo (tazarotene) is a lotion formulation of the approved retinoid tazarotene for the topical treatment of acne vulgaris in patients 9 years of age and older.

Development timeline for Arazlo

Dec 19, 2019Approval FDA Approves Arazlo (tazarotene) Lotion for the Topical Treatment of Acne Vulgaris

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.